Real Chemistry plans to harness the “Wild West” of GLP-1 social media and reams of competitive data in the drug category with a new platform called IRIS.
An all-in-one dashboard sits at the center of the service with real-time data that include clinical trial tracking, script and claims information, consumer behaviors, payer, policy and market access news, and both paid and unpaid communications and media.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.